When was CircleDNA founded?

CircleDNA was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is CircleDNA located?

CircleDNA is headquartered in Hong Kong, China.

Who is the current CEO of CircleDNA?

Danny Yeung and Avi Lasarow s of CircleDNA. Danny Yeung has also founded 1 company.

Is CircleDNA a funded company?

CircleDNA is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Sep 18, 2020.

When was the latest funding round of CircleDNA?

CircleDNA's latest funding was a $***** Series B round on Sep 18, 2020, with participation from 2 investors. Its primary sector is Healthcare Booking Platforms. In China, the Healthcare Booking Platforms sector has seen $19.2M in funding in 2026 to date.

Where does CircleDNA rank among its competitors?

CircleDNA ranks 2nd amongst 10 active competitors, of which 7 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was AnchorDx, which secured $40M in Feb, 2021.

Who are the top competitors of CircleDNA?

CircleDNA's top competitors include AnchorDx, Universal Life and 23Mofang. Among them, AnchorDx secured the most recent funding round in February, 2021.

CircleDNA - 2026 Company Profile, Team, Funding & Competitors

CircleDNA is a series B company based in Hong Kong (China), founded in 2014 by Lawrence Tzang and Danny Yeung. It operates as a Provider of internet first diagnostics platform for genetic tests. CircleDNA has raised $60M in funding from Apis Partners. The company has 10 active competitors, including 7 that are funded. Its top competitors include companies like AnchorDx, Universal Life and 23Mofang.

Company Details

CircleDNA is an internet first diagnostics lab for genetic tests. It offers genetic tests for personalized and proactive health. The company offers test kits for cardiovascular diseases, psychiatric disorders, pain management, miscellaneous common drugs, drug allergies, diabetes, among others. The company uses the technology for Whole Exome Sequencing for detection.

Website: circledna.com
Social
Email ID: *****@circledna.com
Phone Number: +852 **********

Key Metrics

Founded Year

2014

Location

Hong Kong, China

Stage

Series B

Total Funding

$60M in 1 round

Latest Funding Round

Series B, Sep 18, 2020, $*****

Investors

Apis Partners & 1 more

Ranked

2^nd among 10 active competitors

Similar Companies

Invitae & 254 more

View CircleDNA's full profile

CircleDNA has raised a total funding of $60M over 1 round. Its latest funding round was a Series B round on Sep 18, 2020 for $*****. 2 investors participated in its latest round. CircleDNA has 2 institutional investors.

Here is the list of recent funding rounds of CircleDNA:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 18, 2020	4588910	Series B	7627061	2062664	9262993	3527488

Access funding benchmarks and valuations. Sign up today!

View details of CircleDNA's funding rounds and investors

The founders of CircleDNA are Lawrence Tzang and Danny Yeung. Danny Yeung and Avi Lasarow are the CEOs of CircleDNA.

Here are the details of CircleDNA's key team members:

Lawrence Tzang: Co-Founder of CircleDNA.
Danny Yeung: Co-Founder & CEO of CircleDNA.
Avi Lasarow: CEO of CircleDNA.

View details of CircleDNA's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CircleDNA include AnchorDx, Universal Life and 23Mofang. Here is the list of Top 10 competitors of CircleDNA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AnchorDx 2015, Guangzhou (China), Series C	Developer of high throughput gene sequencing platform for clinical application	$73M	Orbimed, Frontline BioVentures & 5 others	48/100
2nd	CircleDNA 2014, Hong Kong (China), Series B	Provider of internet first diagnostics platform for genetic tests	$60M	Apis Partners, Alibaba Entrepreneurs Fund	47/100
3rd	Universal Life 2017, Guangzhou (China), Funding Raised	Developer of molecular diagnostic products and gene therapy solutions	-	Qiming Venture Partners, Tianrui Fengnian Private Equity Fund ... Read more	43/100
4th	23Mofang 2015, Chengdu (China), Series B	Provides genetic testing services to help prevent potential problems and early intervention.	$34.3M	Matrix Partners China, Fenghou Capital & 8 others	41/100
5th	WeGene 2014, Shenzhen (China), Series B	Genetic testing solution	-	K2, Ameba Capital & 1 others	28/100
6th	LeGENE 2012, Hong Kong (China), Unfunded	Provider of personal genetic services	-	-	25/100
7th	MyGene 2014, Beijing (China), Unfunded	Provider of gene mapping technology platform	-	-	24/100
8th	GeseDNA 2014, Beijing (China), Seed	Provider of gene detection and interpretation tool	-	Idaxiang	22/100
9th	1JKT 2014, Shenzhen (China), Seed	Online platform offering appointment booking services for genetic tests	-	CZ Capital	22/100
10th	Pathway Pharmaceuticals 2006, Hong Kong (China), Deadpooled	Platform for quantitative and qualitative analysis of intracellular signalling pathway activation	-	Deep Knowledge Ventures, Deep Knowledge Life Sciences ... Read more	21/100